Newsletter - February 2020
FEATURED CONTENT: The Evolution of Marketing Automation
Despite the recent questions swirling due to data privacy changes (GDPR, CCPA, and the impending “cookie-less” reality), industry experts agree programmatic for pharma will not be hurt by increased privacy legislation or trends.
The bull market position taken by thought leaders is that scaling back now on programmatic “will risk major missed opportunities for greater ROI and better attribution.” Across all sectors, U.S. programmatic media spend totally roughly $60 billion dollars in 2019, and is conservatively estimated by eMarketer to increase to over $80 billion by 2021.
ADDITIONAL INSIGHTS FROM DHC PARTNERS
Via Crossix eBook →
With the increasing focus on privacy across the healthcare industry, executives from Crossix, the Network Advertising Initiative, and Novartis joined together to educate healthcare advertisers during a webcast. They sought to explain current privacy issues in audience targeting and how new guidelines affect and assist advertisers in their work.
Read More →
Via CMI/Compas →
A POV on the ongoing implications of the shifting privacy landscape offered by CMI/Compas will be kept updated on a rolling basis as they monitor for relevant changes. This resource will guide healthcare marketers to the information and strategic recommendations needed to continue to make good decisions for their campaigns.
Read More →
Via PulsePoint →
From conception until death, we worry about our health and wellbeing. Every civilization across the millennium shares this truth. But health is hard to define and treating illnesses is no easy feat. This POV from PulsePoint examines the breakdown between the desire for privacy and the value of transparency.
Read More →
DHC EVENTS COMING SOON
DHC Midwest Summit
Hosted by MATTER
Mark your calendar now to join members of the DHC and industry experts
WHEN: May 28, 2020, 1pm - 5pm, followed by cocktails
DHC PARTNERS IN THE NEWS
DHC is pleased to announce the addition of several industry thought leaders to the DHC Advisory Board including:
- Tricia Brown, Digital and Technology Strategy, Merck
- Pete Dannenfelser, AVP, Communications & Digital Innovation, Ferring Pharmaceuticals
- Paul Ivans, CEO, Evolution Road
- Stefani Klaskow, Industry Health Lead, Google
- Marc Monseau, Founder, Mint Collective
- John Walsh, Head of Commerical IT, Otsuka
New members to the DHC in 2020 include BioPharm, MyHealthTeams, IQVIA, and Truveris. This diverse group of supporting members will be lending their subject matter expertise to DHC education and research efforts, in support of the DHC’s mission to serve as an industry rallying point for the discussion of the current and future issues relevant to digital marketing of healthcare products and services. See DHC Membership Here →
Hosted by the DHC and Healthline
Tried and true digital efforts on contextual and content marketing will win in the new realm of internet browser changes and privacy regulations. Metrics of success and benchmarks will be heavily impacted as a result of an inability to track specific performance measures. If you haven’t heard of ITP, 2.0, or are concerned about what Google Chrome will launch, you will want to view this webinar. View Webinar →